Статті в журналах з теми "Vaccine engineering"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Vaccine engineering".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Rizqoh, Debie. "Genetic Engineering Technique in Virus-Like Particle Vaccine Construction." Jurnal Kesehatan Masyarakat Indonesia 16, no. 4 (December 31, 2021): 203. http://dx.doi.org/10.26714/jkmi.16.4.2021.203-211.
Повний текст джерелаCasiño, Jenny J., and Angelo Mark P. Walag. "Issues and Challenges of, Factors that Affect, and the Primary Influences of Parents’ Decisions to Vaccinate their Adolescents: A Case of a Local National High School in Cagayan de Oro City, Philippines." Canadian Journal of Family and Youth / Le Journal Canadien de Famille et de la Jeunesse 14, no. 1 (January 1, 2022): 147–61. http://dx.doi.org/10.29173/cjfy29752.
Повний текст джерелаSchlotthauer, Felicia, Joey McGregor, and Heidi E. Drummer. "To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity." Viruses 13, no. 5 (April 30, 2021): 805. http://dx.doi.org/10.3390/v13050805.
Повний текст джерелаNuismer, Scott L., Benjamin M. Althouse, Ryan May, James J. Bull, Sean P. Stromberg, and Rustom Antia. "Eradicating infectious disease using weakly transmissible vaccines." Proceedings of the Royal Society B: Biological Sciences 283, no. 1841 (October 26, 2016): 20161903. http://dx.doi.org/10.1098/rspb.2016.1903.
Повний текст джерелаvan der Sanden, Sabine M. G., Weilin Wu, Naomi Dybdahl-Sissoko, William C. Weldon, Paula Brooks, Jason O'Donnell, Les P. Jones, et al. "Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game." Journal of Virology 90, no. 4 (November 18, 2015): 1694–704. http://dx.doi.org/10.1128/jvi.01464-15.
Повний текст джерелаOgonczyk Makowska, Daniela, Marie-Ève Hamelin, and Guy Boivin. "Engineering of Live Chimeric Vaccines against Human Metapneumovirus." Pathogens 9, no. 2 (February 19, 2020): 135. http://dx.doi.org/10.3390/pathogens9020135.
Повний текст джерелаVishweshwaraiah, Yashavantha L., and Nikolay V. Dokholyan. "Toward rational vaccine engineering." Advanced Drug Delivery Reviews 183 (April 2022): 114142. http://dx.doi.org/10.1016/j.addr.2022.114142.
Повний текст джерелаSudhakar, Poda, M. Usha Kiranmayi, Selvaraj Sankarpandian, Manyam Srinivasa Rao, M. Vijayalakshmi, and K. R. S. Sambasiva Rao. "Engineering generic vaccine vectors." International Journal of Biomedical Engineering and Technology 6, no. 1 (2011): 93. http://dx.doi.org/10.1504/ijbet.2011.040455.
Повний текст джерелаChoi, Ji Young, Bhushan Mahadik, and John P. Fisher. "3D printing technologies for in vitro vaccine testing platforms and vaccine delivery systems against infectious diseases." Essays in Biochemistry 65, no. 3 (August 2021): 519–31. http://dx.doi.org/10.1042/ebc20200105.
Повний текст джерелаTripp, Ralph, S. M. G. van der Sanden, W. Wu, N. dybdahl-Sissoko, William Weldon, P. Brooks, J. O'donnell, et al. "Engineering enhanced vaccine cell lines to eradicate vaccine preventable diseases: the polio endgame (VAC9P.1107)." Journal of Immunology 194, no. 1_Supplement (May 1, 2015): 145.15. http://dx.doi.org/10.4049/jimmunol.194.supp.145.15.
Повний текст джерелаMarshall, Sarah, Anne C. Moore, Laura J. Sahm, and Aoife Fleming. "Parent Attitudes about Childhood Vaccines: Point Prevalence Survey of Vaccine Hesitancy in an Irish Population." Pharmacy 9, no. 4 (November 23, 2021): 188. http://dx.doi.org/10.3390/pharmacy9040188.
Повний текст джерелаAbu-Asab, Mones S., Majid Laassri, and Hakima Amri. "Algorithmic Assessment of Vaccine-Induced Selective Pressure and Its Implications on Future Vaccine Candidates." Advances in Bioinformatics 2010 (February 1, 2010): 1–6. http://dx.doi.org/10.1155/2010/178069.
Повний текст джерелаLaudi, Abby. "Identifying the Roles of Medical Providers when Addressing Barriers to HPV Vaccination Rates in Rural NE Clinics." Obstetrics Gynecology and Reproductive Sciences 6, no. 1 (January 5, 2022): 01–07. http://dx.doi.org/10.31579/2578-8965/093.
Повний текст джерелаShchelkunov, Sergey, and G. A. Shchelkunova. "Genes that control vaccinia virus immunogenicity." Acta Naturae 12, no. 1 (April 16, 2020): 33–41. http://dx.doi.org/10.32607/actanaturae.10935.
Повний текст джерелаFioretti, Daniela, Sandra Iurescia, Vito Michele Fazio, and Monica Rinaldi. "DNA Vaccines: Developing New Strategies against Cancer." Journal of Biomedicine and Biotechnology 2010 (2010): 1–16. http://dx.doi.org/10.1155/2010/174378.
Повний текст джерелаRenu, Sankar, Ashley D. Markazi, Santosh Dhakal, Yashavanth Shaan Lakshmanappa, Revathi Shanmugasundaram, Ramesh K. Selvaraj, and Gourapura J. Renukaradhya. "Engineering of Targeted Mucoadhesive Chitosan Based Salmonella Nanovaccine for Oral Delivery in Poultry." Journal of Immunology 200, no. 1_Supplement (May 1, 2018): 118.15. http://dx.doi.org/10.4049/jimmunol.200.supp.118.15.
Повний текст джерелаKashyap, Dharmendra, Mrutyunjaya Panda, Budhadev Baral, Nidhi Varshney, Sajitha R, Vasundhra Bhandari, Hamendra Singh Parmar, Amit Prasad, and Hem Chandra Jha. "Outer Membrane Vesicles: An Emerging Vaccine Platform." Vaccines 10, no. 10 (September 21, 2022): 1578. http://dx.doi.org/10.3390/vaccines10101578.
Повний текст джерелаCid, Raquel, and Jorge Bolívar. "Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies." Biomolecules 11, no. 8 (July 21, 2021): 1072. http://dx.doi.org/10.3390/biom11081072.
Повний текст джерелаNurunnabi, Abu Sadat Mohammad, Shamsi Sumaiya Ashique, Asmay Jahan, Afroza Akbar Sweety, and Saida Sharmin. "Children and COVID-19 Vaccine: A Public Health Ethics Perspective." Bangladesh Medical Journal 50, no. 3 (November 23, 2022): 44–48. http://dx.doi.org/10.3329/bmj.v50i3.62934.
Повний текст джерелаHerrera, Crystal M., Jessicia S. Schmitt, Erum I. Chowdhry, and Mark S. Riddle. "From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review." Vaccines 10, no. 5 (April 20, 2022): 645. http://dx.doi.org/10.3390/vaccines10050645.
Повний текст джерелаİsmail, Karakaş. "Plants That Can be Used as Plant-Based Edible Vaccines; Current Situation and Recent Developments." Virology & Immunology Journal 6, no. 3 (November 4, 2022): 1–10. http://dx.doi.org/10.23880/vij-16000302.
Повний текст джерелаLinhart, Birgit, and Rudolf Valenta. "Vaccine Engineering Improved by Hybrid Technology." International Archives of Allergy and Immunology 134, no. 4 (2004): 324–31. http://dx.doi.org/10.1159/000079535.
Повний текст джерелаPalca, Joseph. "Vaccine engineering: Violation of rules alleged." Nature 321, no. 6067 (May 1986): 190. http://dx.doi.org/10.1038/321190a0.
Повний текст джерелаO'Neill, Julia, George Atkins, Dan Curbison, Betsy Flak, James M. Lucas, Dana Metzger, Lindsay Morse, et al. "Statistical Engineering to Stabilize Vaccine Supply." Quality Engineering 24, no. 2 (April 2012): 227–40. http://dx.doi.org/10.1080/08982112.2012.654325.
Повний текст джерелаZagursky, Robert. "Vaccine discovery research by reverse engineering." Drug Discovery Today 8, no. 21 (November 2003): 972–73. http://dx.doi.org/10.1016/s1359-6446(03)02841-1.
Повний текст джерелаMukhtar, Mamuna, Amtul Wadood Wajeeha, Najam us Sahar Sadaf Zaidi, and Naseeha Bibi. "Engineering Modified mRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches." International Journal of Molecular Sciences 23, no. 22 (November 11, 2022): 13911. http://dx.doi.org/10.3390/ijms232213911.
Повний текст джерелаWilson, Gavin, and Taiwo Aremu. "The Federal Retail Pharmacy Program (FRPP) Impact on COVID-19 Vaccine Distribution During Pandemic: Effectiveness, Limitations, and Implications." INNOVATIONS in pharmacy 13, no. 3 (October 18, 2022): 12. http://dx.doi.org/10.24926/iip.v13i3.5026.
Повний текст джерелаChavda, Vivek P., Md Kamal Hossain, Jayesh Beladiya, and Vasso Apostolopoulos. "Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena." Biologics 1, no. 3 (October 23, 2021): 337–56. http://dx.doi.org/10.3390/biologics1030020.
Повний текст джерелаKostina, L. V., A. D. Zaberezhnyy, T. V. Grebennikova, N. V. Antipova, T. I. Aliper, and E. A. Nepoklonov. "Vaccines against avian influenza in poultry." Problems of Virology, Russian journal 62, no. 2 (April 20, 2017): 53–60. http://dx.doi.org/10.18821/0507-4088-2017-62-2-53-60.
Повний текст джерелаMenon, Ipshita, Priyal Bagwe, Keegan Braz Gomes, Lotika Bajaj, Rikhav Gala, Mohammad N. Uddin, Martin J. D’Souza, and Susu M. Zughaier. "Microneedles: A New Generation Vaccine Delivery System." Micromachines 12, no. 4 (April 14, 2021): 435. http://dx.doi.org/10.3390/mi12040435.
Повний текст джерелаSuvvari, Tarun, Venkataramana Kandi, Divya Bala A. M. R. Salibindla, Simhachalam Kutikuppala, Christos Tsagkaris, and Venkata Narayana Nithish Modala. "Acceptance of COVID-19 Vaccine A mong Residents of South India: A Cross-sectional Survey." Perspectives in Medical Research 9, no. 3 (January 6, 2022): 72–78. http://dx.doi.org/10.47799/pimr.0903.17.
Повний текст джерелаCurrier, Arthur W., Madeline C. Jeshurin, and Valerie B. Sampson. "SARS-CoV-2 Targets and COVID-19 Vaccines." COVID 1, no. 3 (November 17, 2021): 608–21. http://dx.doi.org/10.3390/covid1030051.
Повний текст джерелаBavkar, Bhagyashri, Vaishali Gawade, Kanchan Wagh, and Sonali Dhuttargi. "Secured Quick Vaccine Manager: Smart Schedular, Tracker and Reminder using Cloud Technology." International Journal for Research in Applied Science and Engineering Technology 10, no. 5 (May 31, 2022): 3215–18. http://dx.doi.org/10.22214/ijraset.2022.43040.
Повний текст джерелаGraham, Barney S., Morgan S. A. Gilman, and Jason S. McLellan. "Structure-Based Vaccine Antigen Design." Annual Review of Medicine 70, no. 1 (January 27, 2019): 91–104. http://dx.doi.org/10.1146/annurev-med-121217-094234.
Повний текст джерелаKaushik, Nisha, Arti R. Thakkar, and K. Bangarurajan. "COVID-19 and Standardized Vaccines Development: A Brief Review." Journal of University of Shanghai for Science and Technology 23, no. 05 (May 19, 2021): 325–43. http://dx.doi.org/10.51201/jusst/21/05148.
Повний текст джерелаKim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon, K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. "In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen." Journal of Immunology 158, no. 2 (January 15, 1997): 816–26. http://dx.doi.org/10.4049/jimmunol.158.2.816.
Повний текст джерелаCastilho, Leda R., Nathalia R. Mattos, Wallace S. Abreu, and Melissa L. E. Gutarra. "Virus-Like Particles (VLPs) as Important Tools for Flavivirus Vaccine Development." Biologics 2, no. 4 (October 31, 2022): 226–42. http://dx.doi.org/10.3390/biologics2040018.
Повний текст джерелаDuarte, Raiany Borges, Samara Moreira Felizarda, Mayra Parreira Oliveira, Júlia Martins Soares, Ísis Indaiara Gonçalves Granjeiro Taques, Raphaella Barbosa Meirelles-Bartoli, Dirceu Guilherme de Souza Ramos, and Ísis Assis Braga. "Persistence of vaccine immunity against canine parvovirus and canine distemper virus for determination of vaccine protocol in dogs: impacts and challenges in Brazil." Research, Society and Development 10, no. 11 (August 25, 2021): e127101119472. http://dx.doi.org/10.33448/rsd-v10i11.19472.
Повний текст джерелаMonreal-Escalante, Elizabeth, Abel Ramos-Vega, Carlos Angulo, and Bernardo Bañuelos-Hernández. "Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production." Vaccines 10, no. 1 (January 10, 2022): 100. http://dx.doi.org/10.3390/vaccines10010100.
Повний текст джерелаBhattacharya, Uma, and Mohit Nain. "A Comparative Analysis on the Doses of Covaxin and Covishield Vaccines Administered in India." International Journal for Research in Applied Science and Engineering Technology 10, no. 7 (July 31, 2022): 4431–43. http://dx.doi.org/10.22214/ijraset.2022.41654.
Повний текст джерелаVan Gilder, Deidra, and Shanna K. O'Connor. "Pharmacist Impact on Immunization Rates in Asplenic Patients." INNOVATIONS in pharmacy 13, no. 4 (November 17, 2022): 6. http://dx.doi.org/10.24926/iip.v13i4.4968.
Повний текст джерелаTurbhekar, Karan, and Aditya Srivastava. "Covid-19 Vaccination in India." International Journal for Research in Applied Science and Engineering Technology 10, no. 4 (April 30, 2022): 806–9. http://dx.doi.org/10.22214/ijraset.2022.41350.
Повний текст джерелаFaisol, Wildan, and Nizar Umar. "NASIONALISME VAKSIN SEBAGAI PRAKTIK NEOMERKANTILISME: ANALISA STUDI EKONOMI POLITIK INTERNASIONAL." Review of International Relations 4, no. 1 (July 4, 2022): 55–66. http://dx.doi.org/10.24252/rir.v4i1.27026.
Повний текст джерелаWalpita, Pramila. "Cell Derived Virus-Like Particles (VLP) in Future Vaccine Development." Vaccination Research – Open Journal 2, no. 1 (December 31, 2017): e1-e1. http://dx.doi.org/10.17140/vroj-2-e003.
Повний текст джерелаChen, Shuxiong, Diana H. Quan, Xiaonan T. Wang, Sarah Sandford, Joanna R. Kirman, Warwick J. Britton, and Bernd H. A. Rehm. "Particulate Mycobacterial Vaccines Induce Protective Immunity against Tuberculosis in Mice." Nanomaterials 11, no. 8 (August 13, 2021): 2060. http://dx.doi.org/10.3390/nano11082060.
Повний текст джерелаPozniak, H. "Race for a vaccine [Engineering & Technology]." Engineering & Technology 15, no. 4 (May 1, 2020): 30–33. http://dx.doi.org/10.1049/et.2020.0402.
Повний текст джерелаFrietze, Kathryn M., David S. Peabody, and Bryce Chackerian. "Engineering virus-like particles as vaccine platforms." Current Opinion in Virology 18 (June 2016): 44–49. http://dx.doi.org/10.1016/j.coviro.2016.03.001.
Повний текст джерелаPurwito, Dedy. "From global to local action: rise from the pandemic, an efforts to increase routine immunization coverage." MEDISAINS 20, no. 1 (April 30, 2022): 1. http://dx.doi.org/10.30595/medisains.v20i1.13586.
Повний текст джерелаMasala, G. L., M. Lipsitch, C. Bottomley, and S. Flasche. "Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination." Journal of The Royal Society Interface 14, no. 136 (November 2017): 20170620. http://dx.doi.org/10.1098/rsif.2017.0620.
Повний текст джерелаFishman, Jordan, Leonard Moise, Pierre LeBlanc, Timothy Brauns, Eric Berg, Daniel Richer, Christine Boyle, et al. "VaxCelerate: the use of MTBhsp70-avidin as an adjuvant to rapidly generate self-assembling vaccines with biotinylated, antigen-specific peptides targeting emerging pathogens. (VAC6P.941)." Journal of Immunology 192, no. 1_Supplement (May 1, 2014): 140.2. http://dx.doi.org/10.4049/jimmunol.192.supp.140.2.
Повний текст джерела